@article{article, title  = {{Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial}},

 url = {{http://eprints.whiterose.ac.uk/102408/ }},

 year = {{2016}},

 month = {{11}},

 author = {{Parker C and Finkelstein SE and Michalski JM and O'Sullivan JM and Bruland Ø and Vogelzang NJ and Coleman RE and Nilsson S and Sartor O and Li R and Seger MA et al}},

 doi = {{10.1016/j.eururo.2016.06.002}},

 volume = {{70}},

 journal = {{European Urology}},

 issue = {{5}},

 pages = {{875-883}},

 note = {{Accessed on 2025/10/10}}}